Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms

被引：0
|
作者：
Tashi, Tsewang [1 ]
Deininger, Michael W. [2 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, 2000 Circle Hope, Salt Lake City, UT 84112 USA
[2] Med Coll Wisconsin, Versiti Blood Res Inst, Div Hematol & Oncol, 8727 West Water town Plank Rd, Milwaukee, WI 53226 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2023年 / 43卷 / 04期
关键词：
Systemic mastocytosis; Associated hematologic neoplasm; KIT D816 V; KIT inhibitors; Tryptase; Avapritinib; MAST-CELL DISORDERS; C-KIT MUTATION; IMATINIB MESYLATE; TREATMENT OPTIONS; TYROSINE KINASE; RESPONSE CRITERIA; INTERFERON-ALPHA; TRYPTASE LEVELS; LEUKEMIA; EFFICACY;
D O I：
10.1016/j.iac.2023.04.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：723 / 741
页数：19
相关论文
共 50 条
  • [41] Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
    Pardanani, Animesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (03) : 363 - 377
  • [42] Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management
    Pardanani, Animesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) : 1147 - 1159
  • [43] Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management
    Pardanani, Animesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 612 - 624
  • [44] Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management
    Pardanani, Animesh
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : 251 - 262
  • [45] Primer on Advanced Mastocytosis
    Scherber, Robyn M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S34 - S37
  • [46] Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia
    Fusco, Nicola
    Bonometti, Arturo
    Augello, Claudia
    Fabris, Sonia
    Boiocchi, Leonardo
    Fiori, Stefano
    Morotti, Denise
    Fracchiolla, Nicola
    Berti, Emilio
    Gianelli, Umberto
    HISTOPATHOLOGY, 2017, 70 (06) : 1000 - 1008
  • [47] Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases
    Mimiola, Elda
    Bomben, Riccardo
    De Matteis, Giovanna
    Perbellini, Omar
    Guglielmelli, Paola
    Bonifacio, Massimiliano
    Parisi, Alice
    Gattei, Valter
    Zamo, Alberto
    Mannelli, Francesco
    Garcia Montero, Andrs Celesteino
    Zanotti, Roberta
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 628 - 633
  • [48] Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin
    Gotlib, Jason
    Kluin-Nelemans, Hanneke C.
    Akin, Cem
    Hartmann, Karin
    Valent, Peter
    Reiter, Andreas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 487 - 498
  • [49] Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
    Hartmann, Karin
    Gotlib, Jason
    Akin, Cem
    Hermine, Olivier
    Awan, Farrukh T.
    Hexner, Elizabeth
    Mauro, Michael J.
    Menssen, Hans D.
    Redhu, Suman
    Knoll, Stefanie
    Sotlar, Karl
    George, Tracy I.
    Horny, Hans-Peter
    Valent, Peter
    Reiter, Andreas
    Kluin-Nelemans, Hanneke C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (02) : 356 - +
  • [50] New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis
    Reiter, Andreas
    George, Tracy I.
    Gotlib, Jason
    BLOOD, 2020, 135 (16) : 1365 - 1376
12345